PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
May 29, 2026Anticancer Research

Clinical Outcomes and Prognostic Factors in Patients With Pelvic Sarcomas

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMasanori KawanoYKYuta KubotaIIICHIRO ITONAGA

Discussion

Loading...

Member takes

Overview

Retrospective analysis investigates survival outcomes in pelvic sarcomas, suggesting CIRT improves prognosis.

Key Points

  • This study aims to analyze clinical outcomes and prognostic factors in patients with pelvic sarcomas.
  • Retrospective review of 20 patients treated between 2015 and 2025 at a single institution.
  • Analysis of clinical characteristics, treatment modalities, and outcomes using Kaplan–Meier method.
  • Univariate analyses for associations between clinical variables and survival outcomes.
  • Median overall survival was 33 months and progression-free survival was 32 months.
  • Larger tumor size (≥95 mm) significantly associated with poorer overall survival (OR=21.3, p=0.006).
  • CIRT significantly associated with improved overall survival (OR=0.05, p=0.007).

Cite This Study

Kawano et al. (2026) studied this question.

synapsesocial.com/papers/6a192d13fab5b468c4415eadhttps://doi.org/10.21873/anticanres.18215
View Full Paper
Ask AI
Bookmark
Share